ILiAD Biotechnologies
Weston, Florida, United States · Biotechnology
ILiAD Biotechnologies is a [Phase 3 ready] clinical-stage biotech company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis and other respiratory diseases.
Key facts
- Headquarters
- Weston, Florida, United States
- Employees
- 25
- Industries
- Biotechnology
- Status
- Private
- Website
- iliadbio.com
- Company page
Recent activity at ILiAD Biotechnologies
- : ILiAD Biotechnologies Appoints Antony Blanc as Chief Business Officer
- : ILiAD Biotechnologies secures $115M in an oversubscribed Series B financing led by RA Capital Management for the advancement of its BPZE1 pertussis vaccine.
- : ILiAD Biotechnologies Announces Innovation Passport Designation for BPZE1 Next Generation Intranasal Pertussis Vaccine
- : ILIAD BIOTECHNOLOGIES
- : ILIAD BIOTECHNOLOGIES
- : Iliad Biotechnologies Announces $42.8M Financing Round To Advance Bpze1 Pertussis Vaccine
- : ILIAD BIOTECHNOLOGIES, LLC
- : ILIAD BIOTECHNOLOGIES, LLC
- : ILIAD BIOTECHNOLOGIES, LLC
- : ILIAD BIOTECHNOLOGIES, LLC
ILiAD Biotechnologies funding history
| Date | Round | Amount |
|---|---|---|
| Feb 2026 | Series B | $115.0M |
| Oct 2022 | Seed | $3.0M |
| Sep 2022 | Venture | $42.8M |
| Sep 2022 | Funding Round | $42.8M |
| Mar 2021 | Venture | Undisclosed |
Leadership
- Vivek Samal, Executive Director - Patient Safety
- KEITH RUBIN, Executive Officer, Director
- CUONG DO, Director
- BIN YAN, Director
- COREY HOROWITZ, Director
- ARIEL PABLOS-MENDEZ, Director
- ARIEL PABLOS-MENDEZ, Director
- COREY HOROWITZ, Director
- BIN YAN, Director
- CUONG DO, Director
- KEITH RUBIN, Executive Officer, Director
- BIN YAN, Director
Verified email and direct lines for ILiAD Biotechnologies’s decision-makers are on Fundz. See plans
Employee benefit plans
ILiAD Biotechnologies files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
ILiAD Biotechnologies in the news
- ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer - Business Wire (Aug 11, 2026)
- ILiAD Biotechnologies of Weston raises $115M to advance whooping cough vaccine - refreshmiami.com (Feb 11, 2026)
- ILiAD Appoints Former GSK Exec as Chief Business Officer - Contract Pharma (Aug 11, 2026)
- Press Release Service: Fierce Biotech Names ILiAD Biotechnologies to its 2024 Fierce 15 - CRISPR Medicine News (Aug 05, 2024)
- ILiAD Biotechnologies Announces $115M Oversubscribed Series B Financing to Advance BPZE1 Pertussis Vaccine - Business Wire (Feb 10, 2026)
- ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases - Business Wire (Oct 02, 2026)
- ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting - Business Wire (Jan 27, 2025)
- ILiAD Biotechnologies Announces Planned Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, to Conduct Upcoming Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine - Business Wire (Jun 24, 2024)
Companies similar to ILiAD Biotechnologies
- Sonavex · Biotechnology
- Seegnal eHealth Ltd · Biotechnology
- Navigator Medicines · Biotechnology
- Tenpoint Therapeutics · Biotechnology
- NurExone Biologic · Biotechnology
About ILiAD Biotechnologies: questions and answers
What does ILiAD Biotechnologies do?
ILiAD Biotechnologies is a [Phase 3 ready] clinical-stage biotech company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis and other respiratory diseases.
Where is ILiAD Biotechnologies headquartered?
ILiAD Biotechnologies is headquartered in Weston, Florida, United States.
How many employees does ILiAD Biotechnologies have?
ILiAD Biotechnologies has about 25 employees.
Has ILiAD Biotechnologies raised funding?
Yes. Fundz has recorded 5 funding events for ILiAD Biotechnologies. The most recent, Series B of $115.0M, was in Feb 2026.
What is the latest news on ILiAD Biotechnologies?
On Aug 11, 2026, ILiAD Biotechnologies Appoints Antony Blanc as Chief Business Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy